hoe-777 and methylprednisolone-aceponate

hoe-777 has been researched along with methylprednisolone-aceponate* in 3 studies

Trials

1 trial(s) available for hoe-777 and methylprednisolone-aceponate

ArticleYear
Local tolerability of topically applied methylprednisolone aceponate.
    Journal of the American Academy of Dermatology, 1993, Volume: 28, Issue:5 Pt 1

    Topics: Administration, Cutaneous; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Atrophy; Betamethasone Valerate; Clobetasol; Dermatitis, Phototoxic; Double-Blind Method; Drug Tolerance; Female; Humans; Irritants; Male; Methylprednisolone; Occlusive Dressings; Ointments; Prednisolone; Skin; Skin Tests

1993

Other Studies

2 other study(ies) available for hoe-777 and methylprednisolone-aceponate

ArticleYear
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
    Contact dermatitis, 2018, Volume: 78, Issue:1

    Corticosteroids are among the most commonly used topical drugs. Contact allergy to these exists, but can be easily missed. Corticosteroid screening markers have been included in the baseline series with the aim of detecting most of the sensitized patients.. To assess the prevalence of contact allergy to topical corticosteroids in Spain and examine the usefulness of corticosteroid markers to detect contact allergy to corticosteroids.. In total, 3699 patients referred to 20 dermatology departments across Spain for patch testing with the baseline series, including budesonide and tixocortol pivalate, were also tested with six supplementary corticosteroids (methylprednisolone aceponate, mometasone furoate, prednicarbate, clobetasol propionate, betamethasone 17-valerate, and betamethasone 17,21-dipropionate). Additionally, 2547 (68.8%) patients were tested with hydrocortisone 17-butyrate.. Fifty-four patients showed positive reactions to at least one of all tested corticosteroids (1.46%). Thirty-nine (1.05%) reacted to at least one of the additionally tested corticosteroids; among these, 24 of 39 (61.5%) did not react to any of the corticosteroid allergy screening markers tested.. More than half of the patients who were allergic to the additionally tested corticosteroids were not detected with the corticosteroid allergy markers. An update of the corticosteroid allergy screening markers is encouraged, with consideration of group 3 corticosteroids.

    Topics: Administration, Cutaneous; Adult; Betamethasone; Betamethasone Valerate; Clobetasol; Dermatitis, Allergic Contact; Dermatologic Agents; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Mometasone Furoate; Patch Tests; Predictive Value of Tests; Prednisolone; Prevalence; Prospective Studies; Spain

2018
Lichen Aureus: A Congenital Case?
    Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:10

    Topics: Anti-Inflammatory Agents; Cafe-au-Lait Spots; Child; Dermoscopy; Diagnosis, Differential; Diagnostic Errors; Disease Progression; Humans; Lichenoid Eruptions; Male; Methylprednisolone; Mycosis Fungoides; Pigmentation Disorders; Port-Wine Stain; Prednisolone; Purpura; Skin Pigmentation; Treatment Failure

2017